ATE509107T1 - Aufreinigung von fc-tact-fusionsproteinen unter verwendung der ölkörper-technik - Google Patents

Aufreinigung von fc-tact-fusionsproteinen unter verwendung der ölkörper-technik

Info

Publication number
ATE509107T1
ATE509107T1 AT08708212T AT08708212T ATE509107T1 AT E509107 T1 ATE509107 T1 AT E509107T1 AT 08708212 T AT08708212 T AT 08708212T AT 08708212 T AT08708212 T AT 08708212T AT E509107 T1 ATE509107 T1 AT E509107T1
Authority
AT
Austria
Prior art keywords
purification
fusion proteins
tact
oil body
body technique
Prior art date
Application number
AT08708212T
Other languages
English (en)
Inventor
Henri Kornmann
Gianni Baer
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Application granted granted Critical
Publication of ATE509107T1 publication Critical patent/ATE509107T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatment Of Sludge (AREA)
AT08708212T 2007-01-26 2008-01-25 Aufreinigung von fc-tact-fusionsproteinen unter verwendung der ölkörper-technik ATE509107T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88668107P 2007-01-26 2007-01-26
EP07101233 2007-01-26
PCT/EP2008/050886 WO2008090217A1 (en) 2007-01-26 2008-01-25 Purification of fc-tact fusion proteins using the oilbody technology

Publications (1)

Publication Number Publication Date
ATE509107T1 true ATE509107T1 (de) 2011-05-15

Family

ID=38143807

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08708212T ATE509107T1 (de) 2007-01-26 2008-01-25 Aufreinigung von fc-tact-fusionsproteinen unter verwendung der ölkörper-technik

Country Status (9)

Country Link
US (1) US20100063257A1 (de)
EP (1) EP2121931B1 (de)
JP (1) JP2010516744A (de)
AT (1) ATE509107T1 (de)
AU (1) AU2008208837A1 (de)
CA (1) CA2674213A1 (de)
ES (1) ES2366593T3 (de)
IL (1) IL199752A (de)
WO (1) WO2008090217A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI377954B (en) * 2009-11-25 2012-12-01 Univ China Medical Oil body carriers, uses in target therapy and/or detection of the same, and fusion proteins comprised therein
TW202208414A (zh) 2020-05-08 2022-03-01 美商艾爾潘免疫科學有限公司 April及baff抑制性免疫調節蛋白及其使用方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2145744T5 (es) 1991-01-18 2008-02-01 Amgen Inc. Procedimientos para tratar las enfermedades inducidas por el factor de necrosis tumoral.
SI0950067T1 (sl) * 1996-11-27 2007-12-31 Genentech Inc Afinitetno čiščenje polipeptida na proteinskemA matriksu
US5856452A (en) * 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices
US5969102A (en) 1997-03-03 1999-10-19 St. Jude Children's Research Hospital Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
PT1642972E (pt) 1999-01-07 2010-04-07 Zymogenetics Inc Utilizações terapêuticas de receptores solúveis br43x2
ATE542545T1 (de) 2001-05-24 2012-02-15 Zymogenetics Inc Taci-immunoglobulin-fusionsproteine
AU2003210802B2 (en) * 2002-02-05 2009-09-10 Genentech Inc. Protein purification
DK1678208T3 (da) * 2003-10-27 2013-07-08 Wyeth Llc Fjernelse af aggregater med høj molekylvægt under anvendelse af hydroxyapatitchromatografi
JP2010510963A (ja) * 2006-06-14 2010-04-08 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー セラミックヒドロキシアパタイトを使用する抗体の精製方法

Also Published As

Publication number Publication date
EP2121931B1 (de) 2011-05-11
US20100063257A1 (en) 2010-03-11
ES2366593T3 (es) 2011-10-21
WO2008090217A1 (en) 2008-07-31
IL199752A0 (en) 2010-04-15
EP2121931A1 (de) 2009-11-25
CA2674213A1 (en) 2008-07-31
AU2008208837A1 (en) 2008-07-31
JP2010516744A (ja) 2010-05-20
IL199752A (en) 2012-07-31

Similar Documents

Publication Publication Date Title
SG162687A1 (en) Caustic stable chromatography ligands
ATE453634T1 (de) Regioselektives verfahren zur zubereitung von benzimidazol-thiophenen
EA200971142A1 (ru) Система экспрессии гетерологичных и гомологичных целлюлаз
DE602008006293D1 (de) System zur Verschleißminderung von Gelenkoberflächenimplantaten
DE602006014126D1 (de) Zusammensetzungen und verfahren zur trennung von fusionsproteinen
DK1984517T3 (da) Fremgangsmåde til modulering af rekombinante proteiners mannoseindhold
SG10201807877TA (en) Hybrid immunoglobulin containing non-peptidyl linkage
UA110600C2 (uk) Спосіб отримання захищених похідних l-аланіну
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
DE602006006765D1 (de) Verfahren zur Identifizierung von GLP-1-Sekretionsförderern
ZA200900836B (en) Process for the purification of FC-fusion proteins
MX347257B (es) Solido de gamma-carbolinas fusionadas con heterociclos substituidos.
EA201101306A1 (ru) Способ повышения выхода полипептидов
DK2061897T3 (da) Fed-batch-fermenteringsproces med høj celledensitet til fremstilling af rekombinant protein
AR113492A2 (es) Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla
DK1948804T3 (da) Fremgangsmåder til fremstilling af modulære fusionsproteinekspressionsprodukter
CA2705357C (en) Formulations for taci-immunoglobulin fusion proteins
ATE474917T1 (de) Verfahren zur erhöhung der in-vivo-gewinnung therapeutischer polypeptide
ATE486128T1 (de) Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine
ATE484749T1 (de) Von anti-trichinella-antikörpern erkannte polypeptide und ihre verwendung
EA201190274A1 (ru) Конструкции casb7439
DE602007002539D1 (de) Prozesssteuerungssystem zur Erzeugung von Funktionsblöcken
IN2014DN06660A (de)
ATE466874T1 (de) Mit scytovirin der domäne 1 verwandte polypeptide
ATE509107T1 (de) Aufreinigung von fc-tact-fusionsproteinen unter verwendung der ölkörper-technik

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties